Differentiated Thyroid Cancer (DTC)

Also known as: Differentiated Thyroid Cancer

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB09100Thyroid, porcine1Completed1
DB00024Thyrotropin alfa1Completed1
DB11595Atezolizumab1 / 2Recruiting1
DB05153Cabozantinib1 / 2Recruiting1
DB08875Cabozantinib1 / 2Recruiting1
DB00773Etoposide1 / 2Completed1
DB01181Ifosfamide1 / 2Completed1
DB09078Lenvatinib1 / 2Completed1
DB00024Thyrotropin alfa1 / 2Recruiting1
DB15414CM-43072Completed1
DB11891CUDC-9072Terminated1
DB08875Cabozantinib2Active Not Recruiting2
DB01590Everolimus2Completed1
DB09078Lenvatinib2Active Not Recruiting1
DB09078Lenvatinib2Not Yet Recruiting1
DB09079Nintedanib2Active Not Recruiting1
DB00398Sorafenib2Active Not Recruiting1
DB00398Sorafenib2Completed1
DB01268Sunitinib2Completed1
DB05294Vandetanib2Active Not Recruiting1
DB11885Anlotinib2 / 3Active Not Recruiting1
DB15414CM-43073Recruiting1
DB08875Cabozantinib3Recruiting1
DB05382Iodine3Terminated1
DB09078Lenvatinib3Active Not Recruiting1
DB14765Rivoceranib3Active Not Recruiting1
DB11689Selumetinib3Terminated1
DB00024Thyrotropin alfa3Completed1
DB05294Vandetanib3Active Not Recruiting1
DB00630Alendronic acidNot AvailableRecruiting1
DB06724Calcium carbonateNot AvailableRecruiting1
DB00169CholecalciferolNot AvailableRecruiting1
DB09078LenvatinibNot AvailableApproved for Marketing1
DB14227Technetium Tc-99mNot AvailableRecruiting1